Chris L. Clayton - Concepedia

Author

Chris L. Clayton

GlaxoSmithKline (United Kingdom)

Also Known As

CHRIS CLAYTON, Chris Clayton, Chris L Clayton, Chris L. Clayton

Publications

894

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)University of Manchester Age UK University College London University of Sheffield

About

Chris L. Clayton is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, immunology, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	233
2	Health Sciences	2	2	94
3	Engineering	1	1	70
4	Allergy	1	1	58
5	Biostatistics	1	1	70

Chris L. Clayton

Publications

839

Citations

H-Index

Page 1

	Year	Citations
Iron acquisition and virulence in <i>Helicobacter pylori</i>: a major role for FeoB, a high‐affinity ferrous iron transporter Jyoti Velayudhan, Nicky J. Hughes, Andrew A. McColm, Molecular Microbiology	2000	314
<i>Helicobacter pylori porCDAB</i>and<i>oorDABC</i>Genes Encode Distinct Pyruvate:Flavodoxin and 2-Oxoglutarate:Acceptor Oxidoreductases Which Mediate Electron Transport to NADP Nicky J. Hughes, Chris L. Clayton, Peter A. Chalk, Journal of Bacteriology	1998	136
Use of gene expression profiling to identify a novel glucocorticoid sensitivity determining gene, BMPRII Rachelle Donn, Adam Stevens, Stuart Farrow, The FASEB Journal EngineeringGeneticsImmunologyImmune RegulationDisease Gene Identification	2006	70
Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophages Lauren Kent, Lucy Smyth, Chris L. Clayton, Cytokine InflammationTobacco ControlMedicineNicotineImmunology	2008	69
Large-scale analysis of gene expression changes during acute and chronic exposure to Δ<sup>9</sup>-THC in rats Josef T. Kittler, Elena Grigorenko, Chris L. Clayton, Physiological Genomics Hippocampal Mrna ProbesImmunologyGene Expression ChangesToxicological MechanismTranscriptional Regulation	2000	58
Inhibition of Lipopolysaccharide-Stimulated Chronic Obstructive Pulmonary Disease Macrophage Inflammatory Gene Expression by Dexamethasone and the p38 Mitogen-Activated Protein Kinase Inhibitor N-cyano-N′-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504) Lauren Kent, Lucy J.C. Smyth, Jonathan Plumb, Journal of Pharmacology and Experimental Therapeutics	2008	50
Behavior and Target Site Selection of Conjugative Transposon Tn <i>916</i> in Two Different Strains of Toxigenic Clostridium difficile Peter Mullany, Rachel Williams, Gemma C. Langridge, Applied and Environmental Microbiology Microbial PathogensBacteriologyMolecular BiologyTn916 Insertion LibrariesBacterial Pathogens	2012	36
Regulation of Wnt4 in chronic obstructive pulmonary disease Andrew Durham, Alistair S. McLaren, B. P. Hayes, The FASEB Journal	2013	36
Gene expression profiles in the rat streptococcal cell wall-induced arthritis model identified using microarray analysis Inmaculada Rioja, Chris L. Clayton, Simon J. Graham, Arthritis Research & Therapy	2004	31
Gene expression changes caused by the p38 MAPK inhibitor dilmapimod in COPD patients: analysis of blood and sputum samples from a randomized, placebo‐controlled clinical trial Joanna Betts, Ruth J. Mayer, Ruth Tal‐Singer, Pharmacology Research & Perspectives	2014	25

Page 1